	Ebitda		日
AbbVie	USD 5.37B	1.85B	2025-12
Amgen	USD 5.14B	775M	2025-12
Anika Therapeutics	USD 4.54M	3.67M	2025-12
Arrowhead Research	USD 64.2M	223.53M	2025-09
AstraZeneca	USD 5.67B	1.29B	2026-03
BioCryst Pharmaceuticals	USD 51.7M	30.14M	2025-09
Biogen	USD 649.7M	76.5M	2026-03
Bristol-Myers Squibb	USD 2.88B	1.36B	2025-12
Gilead Sciences	USD 3.02B	1.01B	2025-12
GlaxoSmithKline	GBP 2.77B	1.65B	2026-03
Halozyme Therapeutics	USD 21.9M	226.34M	2025-12
Heron Therapeutics	USD -3.88M	5.63M	2024-09
Immunic	USD -22.78M	753K	2024-06
Incyte	USD 367.97M	46.53M	2026-03
Insmed	USD -314.19M	31.48M	2025-12
Ionis Pharmaceuticals	USD -200.02M	42.89M	2025-12
J&J	USD 7.19B	2.32B	2025-12
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
Ligand Pharmaceuticals	USD 150.32M	129.42M	2025-09
Merck	USD 6.3B	2.09B	2025-12
Neurocrine Biosciences	USD 218.4M	28.3M	2025-12
Novartis	USD 5.3B	530M	2026-03
Novavax	USD 19.36M	190.79M	2025-12
Pfizer	USD 756M	5.32B	2025-12
PTC Therapeutics	USD -70.99M	91.62M	2025-12
Roche Holding	CHF 12.68B	2.36B	2024-06
Sarepta Therapeutics	USD -168.03M	294.45M	2025-09
Vertex Pharmaceuticals	USD 1.39B	48.8M	2025-12